- About Us
- Guidelines
-
The Author ensures that the research has been conducted responsibly and ethically with adherence to all relevant regulations. read more..
- For Authors
- For Reviewer
- Manuscript Guidelines
- Membership
- Publication Ethics
-
- Journals
- Reprints
- e-Books
- Videos
- Indexing
- Contact Us
COVID-19
- Submissions
Abstract
Novel Research in Sciences
What’s Next for mRNA Vaccines?
-
Open or CloseJoseph F Murphy*
Founder and president, immune PCS LLC, Quincy, MA 02169, USA
*Corresponding author: Joseph F Murphy, Founder and president, immune PCS LLC, Quincy, MA 02169, USA
Submission: October 14, 2021;Published: November 29, 2021
.jpg)
Abstract
The recent COVID-19 pandemic has shone a spotlight on a revolutionary technology called messenger RNA (mRNA). What is not so well known is that mRNA has been in the research and development sphere for about three decades. Now that the Pfizer/BioNTech and Moderna vaccines have been shown to be both safe and effective, researchers expect to be able to use this technology to create rapid-response vaccines in the future. Not alone do the mRNA vaccines have the potential to swiftly combat viral pandemics, but also generate promising treatments in other strategic areas, such as immunology, oncology, and rare diseases. Personalized Medicine [1].
Editor In Chief
.jpg)
Signup for Newsletter
Quick Links
Editorial Board Registrations
Submit your Article
Best Paper of the Volume
Reprints
Refer a Friend
Advertise With UsOur Recent Edition
.jpg)
Top Editors
.jpg)
.bmp)
.jpg)
.png)
.jpg)
.jpg)
.png)
.png)
.png)
Financial Support
Sponsors
Latest e-Books
Latest Video
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in 
| Above IE 9.0 version